Two Sigma Advisers’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
Other funds holding TARA
RCM
OM
VCIM
SCM
IHAM
Two Sigma Advisers's TARA Position: Q4 2024 in Review
Two Sigma Advisers sold out of Protara Therapeutics (TARA) in Q4 2024, closing a stake of 151,618 shares — an estimated $277K sold.
Two Sigma Advisers first reported a position in TARA in Q4 2020 and held it in 16 quarters. The position peaked at $1.17M in Q3 2021. 60 funds tracked by Wall St. Rank hold TARA as of Q4 2024.
- Two Sigma Advisers reported no remaining Protara Therapeutics position as of Q4 2024 after selling out during the quarter.
- Two Sigma Advisers sold 151,618 Protara Therapeutics shares in Q4 2024, an estimated $277K.
- Two Sigma Advisers first reported a position in Protara Therapeutics in Q4 2020 and held it in 16 quarters.
- Two Sigma Advisers's Protara Therapeutics position peaked at $1.17M in Q3 2021.
- 60 funds tracked by Wall St. Rank held Protara Therapeutics as of Q4 2024.
Based on Two Sigma Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.